Genetic background influences therapeutic effectiveness of VEGF (Q79085598)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

title

Genetic background influences therapeutic effectiveness of VEGF (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

14 March 2024

author name string

Keiko Fukino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

Masataka Sata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

Yoshinori Seko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

Yasunobu Hirata

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

Ryozo Nagai

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511661

14 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

10 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511661

full work available at URL

14 March 2024

number of pages

5

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0006291X03017546?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

https://api.elsevier.com/content/article/PII:S0006291X03017546?httpAccept=text/plain

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Biochemical and Biophysical Research Communications

14 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

volume

310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

143-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

19 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Therapeutic angiogenesis for ischemic cardiovascular disease

14 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation

14 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia

14 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

14 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

14 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

14 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Mouse model of angiogenesis

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

14 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Age-dependent impairment of angiogenesis

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Vascular biology in genetically altered mice : smaller vessels, bigger insight

14 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

The rise of the mouse, biomedicine's model mammal

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

A physical map of the mouse genome

14 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors

14 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Endothelial cell apoptosis induced by oxidized LDL is associated with the down-regulation of the cellular caspase inhibitor FLIP.

14 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Gene transfer into muscle by electroporation in vivo.

14 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis

14 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals

14 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2003.08.134

14 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14511661 AND SRC:MED&resulttype=core&format=json

19 December 2019

1 reference